The RAF kinase inhibitor protein (RKIP) suppresses the expression of many prometastatic genes in triple-negative breast cancer (TNBC) cells by reversing the biological activities of HMGA2 [152,153]. The gene discussed is PEBP1; the disease is triple-negative breast carcinoma.